Analysts Set Vitalhub Corp. (TSE:VHI) Price Target at C$13.86

Vitalhub Corp. (TSE:VHI) has received a consensus rating of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is C$13.86.

VHI has been the subject of several recent analyst reports. Scotiabank dropped their price objective on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating for the company in a research note on Wednesday, February 4th. Raymond James Financial dropped their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research note on Tuesday, March 24th. ATB Cormark Capital Markets dropped their price objective on shares of Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a research note on Tuesday, March 10th. Finally, Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating for the company in a research note on Monday, January 26th.

Vitalhub Stock Up 3.6%

TSE VHI opened at C$8.04 on Friday. The company has a fifty day moving average of C$7.69 and a two-hundred day moving average of C$8.93. The firm has a market capitalization of C$508.39 million, a price-to-earnings ratio of 80.40, a PEG ratio of 1.18 and a beta of 0.90. Vitalhub has a 52 week low of C$6.67 and a 52 week high of C$14.64.

Vitalhub (TSE:VHI) last posted its quarterly earnings data on Wednesday, March 18th. The company reported C$0.06 EPS for the quarter. The company had revenue of C$31.39 million during the quarter. Vitalhub had a net margin of 5.61% and a return on equity of 2.75%. Equities research analysts anticipate that Vitalhub will post 0.2296467 EPS for the current year.

Insiders Place Their Bets

In related news, Director Francis Nelson Shen bought 50,000 shares of the stock in a transaction dated Thursday, March 26th. The stock was purchased at an average cost of C$6.99 per share, with a total value of C$349,500.00. Following the completion of the purchase, the director owned 50,000 shares of the company’s stock, valued at C$349,500. This trade represents a ∞ increase in their ownership of the stock. Also, Director Anthony Pius Shen bought 7,000 shares of the stock in a transaction dated Monday, March 30th. The shares were bought at an average cost of C$7.11 per share, with a total value of C$49,770.00. Following the completion of the purchase, the director directly owned 12,470 shares of the company’s stock, valued at approximately C$88,661.70. This trade represents a 127.97% increase in their position. Insiders have bought 496,600 shares of company stock valued at $3,476,470 over the last three months. Insiders own 18.57% of the company’s stock.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.